psmarketresearch1’s blog

All about market research update

Pain Management Devices Market Trends, Size, Growth and Forecast, 2023

f:id:vijaymishrapsmarket1:20171024073407j:plain

The global pain management devices market is growing significantly due escalating technological advancement and massive research and development in pain management, increasing demand for point-of-care testing, and reappearance of pain after surgery. Increasing necessity for long-term rehabilitation pain management intended for geriatric population, unmet requirements for neuropathic pain, and increasing government initiatives to develop chronic pain rehabilitation centers in order to improve quality of life are supporting the growth of the global pain management devices market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/pain-management-devices-market

Massive unexplored market in pain management devices industry of developing economies are creating abundant opportunities for the pain management devices market to grow at a considerable rate during the projected years. In addition, the advanced research and development facilities, and innovative product developments by the companies are propelling the growth of the pain management devices industry.

The analgesic infusion pumps are further segmented on the basis of type as intrathecal infusion pumps, and external infusion pumps. The electrical stimulators can be further categorized as transcutaneous electrical nerve stimulator and other electrical stimulators; whereas, the neurostimulation devices can be further categorized as deep brain stimulator, spinal cord stimulator, sacral neurostimulator, and others. On the basis of application, the market can be segmented as neuropathic pain, musculoskeletal pain, cancer pain, facial and migraine pain, trauma prompted pain and others.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/pain-management-devices-market/report-sample

Some of the companies operating in the global pain management devices market are B. Braun Melsungen AG, Codman And Shurtleff, Inc., Stryker Corporation, Baxter International, Inc., DJO Global LLC., Boston Scientific Corporation, Medtronic, Inc., Hospira Inc., Smith Medical, Kimberly-Clark Corporation, and St. Jude Medical, Inc.

Nerve Repair and Regeneration Market Analysis, Drivers, Trends, Challenges & Forecast

f:id:vijaymishrapsmarket1:20171018045410j:plain

The global nerve repair and regeneration market is likely to grow significantly during the forecast period, due to increasing geriatric population, rising prevalence of chronic pain and increasing incidence of neurological disorders. In addition, the awareness about mental diseases and their treatment and technological advancement in nerve repair and regeneration products is also increasing globally, which contributes to the growth of the market. Lack of skilled professionals, high cost and side effects associated with the usage of neurostimulation and neuromodulation devices are the key factors restraining the global market growth.

Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/nerve-repair-and-regeneration-market/report-sample

The market for neurostimulation and neuromodulation devices was larger than the market for biomaterials. Internal devices form the larger part of the global neurostimulation and neuromodulation devices market. Within internal neurostimulation and neuromodulation devices, spinal cord stimulation devices generate the largest revenue in the global market. Based on application, neurostimulation and neuromodulation surgeries has been the largest application area of the global nerve repair and regeneration market, followed by direct nerve repair/neurorrhaphy, nerve grafting and stem cell therapy.

Geographically, North America has been the largest market for nerve repair and regeneration, with the U.S. being the largest contributor to the regional market. Increasing incidence of peripheral nerve injuries and presence of technological advanced products has been driving the growth of the North American market. In Europe, Germany has been the largest contributor to the nerve repair and regeneration market, followed by the U.K. and France. The market is expected to witness highest growth in Asia-Pacific, during 2017 - 2023, owing to increasing cases of neurological disorders and increasing geriatric population.

Explore Report at: https://www.psmarketresearch.com/market-analysis/nerve-repair-and-regeneration-market

Some of the key players in the global nerve repair and regeneration market include Boston Scientific Corporation, Axogen, Inc., Cyberonics, Inc., Medtronic, PLC, Baxter International Inc., St. Jude Medical, Inc., Integra Lifesciences Holdings Corporation, Inc., Stryker Corporation, Orthomed S.A.S. and Polyganics B.V.

 

Physiotherapy Equipment Market Analysis, Trends, Growth and Demand, 2023

 

The global physiotherapy equipment market is significantly growing due to technological advancements, such as implanted devices, rehabilitation robots, exoskeleton, and others. The technological advancements, such as implanted devices, help to increase the patient’s comfort level and improve patient care. The increasing demand for home physiotherapy and portable physiotherapy equipment are also creating growth opportunities for the global physiotherapy equipment market. The massive unexplored market in the physiotherapy equipment industry of the developing economies is creating abundant growth opportunities for the physiotherapy equipment market to grow at a considerable rate during the forecast period.

Explore more or request TOC on “Global Physiotherapy Equipment Market” at: https://www.psmarketresearch.com/market-analysis/physiotherapy-equipment-market

In addition, the advanced research and development facilities, and innovative product developments by the companies are propelling the growth of the physiotherapy equipment industry. Physiotherapy is provided to restore the body functioning, as per the biomechanics and anatomical position of an individual. Physiotherapy includes electrotherapy, exercise therapy, hydrotherapy, and cryotherapy, which helps a patient to recover from medical conditions and improve his health.

On the basis of product, the physiotherapy market can be categorized as equipment and accessories, where equipment leads the market in terms of market size. Equipment is further segmented into ultrasound, continuous passive motion (CPM), hydrotherapy, electrical stimulation, heat therapy, and therapeutic exercises. Cryotherapy is a new technology, which is gaining popularity among athletes. Further, the accessories are segmented as orthoses and other assistive devices, such as wheel chairs and crutches.

Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/physiotherapy-equipment-market/report-sample

Geographically, North America is likely to dominate the global physiotherapy equipment market in the coming years, due to upsurge in geriatric population and increasing prevalence of cardiovascular and neurological diseases. Asia-Pacific is the fastest growing region in the global physiotherapy equipment market, due to increasing healthcare expenditure, presence of huge pool of patients, intensifying government support, and up surging prevalence of cardiovascular, musculoskeletal, and neurological diseases in the region. Moreover, the physiotherapy equipment market is growing due to increasing awareness among the population, and refining healthcare infrastructure in the emerging countries, such as India and China.

Some of the companies operating in the global physiotherapy equipment market are BTL Industries, Djo Global, Body Sport, HMS Medical Systems, Isokinetics Inc., ENRAF-Nonius B.V., EMS Physio Ltd., Patterson Companies Inc., and Morris Group Internationals.

Guidewires Market Size, Analysis, Trends, Challenges & Forecast to 2023

f:id:vijaymishrapsmarket1:20171006060749p:plain

The global guidewires market is growing, due to the increase in minimally invasive procedures. The increasing aging population and chronic diseases is also fuelling the growth of the global market. Furthermore, the worldwide growing prevalence of cardiovascular procedures across various age groups results in more number of cases undergoing PCI (Percutaneous Coronary Interventions) procedures, which is boosting the growth of the global market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/guidewires-market

A guidewire is a very thin tube on which catheter is placed, and it is inserted into the artery and moved towards the area of blockage. A guidewire helps in positioning, inserting, and moving catheter inside an artery to treat blockages. During the stenting procedure, a stent is placed over the balloon catheter, which is associated with a guidewire and then moved towards the blockage area in the artery. The balloon inflates inside the artery allowing the plaque to compress, leading to the opening of the artery. A stent then expands inside the artery and forms a scaffold. This allows artery to remain open, improve blood flow, and prevents reclosing of the artery. A coronary guidewire is inserted in care of coronary intervention procedure; whereas, peripheral guidewire is inserted in case of peripheral vascular intervention procedure.

Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/guidewires-market/report-sample

Some of the major companies operating in the global guidewires market are Abbott Laboratories, Terumo Corporation, ASAHI INTECC, Medtronic Inc., Cordis Corporation, Boston Scientific Corporation, Stryker, B. Braun, and Cook Medical.

 

HIV Diagnosis Market - Share, Analysis, Drivers, Growth Rate & Demand, 2023

f:id:vijaymishrapsmarket1:20171004052037j:plain

The global HIV diagnosis market is likely to grow significantly during the forecast period, due to rising prevalence of HIV/AIDS, growing awareness leading to high number of blood donations and blood transfusions, and advantageous features of point of care instruments and kits. In addition, rising healthcare expenditure on HIV and related activities further contributes to the growth of the overall market. High cost of automated HIV diagnosis procedures and lack of skilled professionals are some of the key factors restraining the growth of global HIV diagnosis market.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/hiv-diagnosis-market/report-sample

As per the findings of the research, based on products, consumables segment is the largest product category in the global HIV diagnosis market. Antibody test has been the largely performed test of the global HIV diagnosis market, followed by viral load, CD4, early infant diagnosis and viral identification. Diagnostic laboratories have been the largest end user of HIV diagnosis, followed by hospitals, research institutes and others.

The healthcare expenditure for the purpose of alleviating the potential epidemic situation of HIV, has increased over the past few years in many low and middle income as well as developing countries. According to the data published by UNAIDS, $19.0 billion was spent on the HIV and AIDS related activities in low- and middle-income countries in 2015, of which 57% came from domestic budgets of the governments of these countries. Considering the increasing incidence of HIV, the UNAIDS estimated that approximately $26.2 billion will be required to respond to the epidemic of HIV infection expected in 2020 and around $23.9 billion will be required for the same, in 2030. The variation in healthcare spending across regions is thought to be related to the relative burden of the disease in that region, which in case of Sub-Saharan Africa is significantly high. The overall healthcare spending on HIV and related activities has increased over the years, which in turn is expected to drive the growth of the global HIV diagnosis market.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=hiv-diagnosis-market

Some of the key players in the global HIV diagnosis market include Siemens AG, F. Hoffman La Roche Ltd., Danaher Corporation, Abbott Laboratories, Ltd., Thermo-Fisher Scientific Inc., Merck KGaA, Becton, Dickinson & Company, Alere Inc., Bio-Rad Laboratories and Hologic Inc.

Medical Aesthetics Market - Analysis, Drivers, Growth Rate, Specifications and Forecast 2023

f:id:vijaymishrapsmarket1:20170929073827j:plain

The global medical aesthetics market is likely to grow from $8.6 billion in 2016 to $19.4 billion by 2023. Advancement in laser technology, growing awareness among consumers, and health benefits of medical aesthetics procedures have been driving the global medical aesthetics market. The market is further expected to gain revenue due to shift in the preference from surgical to non-surgical procedures. There has been a significant growth in non-surgical medical spa procedures in the recent years, resulting from better technologies, such as intense pulsed light and advanced laser based aesthetics equipment.

Browse Report Sample at: https://www.psmarketresearch.com/market-analysis/medical-aesthetics-market/report-sample

As per the findings of research, injectables held the largest share in the global market in 2016, primarily due to high sales of botulinum toxin. Topicals, the second largest medical aesthetics product segment, witnessed the highest growth during 2013 – 2016. The highest growth of topicals is attributed to their ability to treat several skin conditions without any usage of uncomfortable procedures. Beauty clinics and centers was the largest end user of the global medical aesthetics market in 2016., followed by spas and salons.

The medical aesthetics market has witnessed number of mergers and acquisitions and strategic alliances recently. In December 2016, Allergan Plc. acquired LifeCell, a medicine company of Acelity L.P. Inc., for a cash consideration of $2.9 billion. The acquisition is expected to combine LifeCell’s business of regenerative medicines with Allergan’s medical aesthetics business. Allergan aims to strengthen its presence in regenerative medicine business with this acquisition. In April 2016, the company also acquired Topokine Therapeutics, a private company developing topical medicines for fat reduction, for a total consideration of $85.0 million. Topokine Therapeutics’ XAF5 is in late-stage development for the treatment of steatoblepharon.

Access Report Overview: https://www.psmarketresearch.com/market-analysis/medical-aesthetics-market

Some of the other key players in the market include Allergan Plc, Valeant Pharmaceuticals International, Inc., ZELTIQ Aesthetics, Inc., Johnson & Johnson, Cutera Inc., Alma Lasers Ltd., Merz GmbH & Co. KGaA, Galderma S.A., Syneron Medical Ltd., Cynosure, Inc., Photomedex, Inc. and Lumenis Ltd.

Needle-Free Diabetes Management Market Drivers, Opportunities, and Challenges

f:id:vijaymishrapsmarket1:20170927072051j:plain

The study suggests that the global needle free diabetes management market is likely to grow from $3,830.6 million in 2016 to $16.8 billion by 2025. With the explosive growth of needle-free treatment devices and the increasing awareness regarding the safety issues associated with needles, the needle-free diabetes management market is gaining traction. The growing need for development of safe needle-free diagnostic device has fueled the demand for continuous blood glucose monitoring across all regions worldwide.

Browse Report Sample at: https://www.psmarketresearch.com/market-analysis/needle-free-diabetes-management-market/report-sample

The factors driving the growth of the market include increasing awareness regarding the safety issues associated with needles and high prevalence of diabetes globally. Needle stick injury during insulin administration can lead to blood-borne pathogen transmission, and hence healthcare workers or patients experience anxiety, fear and emotional distress due to needle stick injury. The risk of needle stick injury is eliminated through needle-free diabetes management. Globally, approximately 16 billion injections are administered every year as per WHO; however, all the syringes and needles are not properly disposed of. This creates huge traction for needle-free diabetes management devices in the healthcare industry. The prevalence of diabetes is increasing due to the alteration in lifestyle and lack of access to preventive care. According to the International Diabetes Federation (IDF), about 415 million people worldwide were suffering from diabetes in 2015 and the number is expected to increase to 642 million by 2040. This reflects the growing need for improved diabetes management, for which needle-free diabetes management can be one of the prospective solutions.

Browse the Report Summary at: https://www.psmarketresearch.com/market-analysis/needle-free-diabetes-management-market

The research states that the manufacturers in the needle-free diabetes management market are focusing continually on workflow enhancements and improving diabetes management and device performance. Currently, the healthcare cost is outpacing the government expenditure on healthcare. The development of technologically advanced diabetes management devices has become necessary to ensure increased healthcare efficiency and productivity. Some of the key players in the global market include Medtronic plc, Insulet Corporation, Tandem Diabetes Care, Inc., Inovio Pharmaceuticals, Inc., Pharmajet, Inc., Zogenix, Inc., Antares Pharma Inc., and Glide Pharmaceutical Technologies Ltd.